• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Using Big data for an Economic Evaluation of reducing the Innappropriate prescribing of atypical Antipsychotics among Dementia Patients
This study is an economic evaluation of the NPS MedicineWise educational program in terms of reduced falls and stroke incidence due to reduction in antipsychotic prescribing including olanzapine, quetiapine and risperidone
Source: Value in Health - May 1, 2015 Category: Global & Universal Authors: R. Khan, A. Jammali-Blasi, A. Todkar, A. Heaney Source Type: research

Media dementia scare over hay fever and sleep drugs
Conclusion This large US prospective cohort study suggests a link between those taking high levels of anticholinergic medicines for more than three years and developing dementia in adults over 65. The main statistically significant finding was in a group taking the equivalent of any of the following medications daily for more than three years: xybutynin chloride, 5mg chlorpheniramine maleate, 4mg olanzapine, 2.5mg meclizine hydrochloride, 25mg doxepin hydrochloride, 10mg These are not unrealistic doses of medicine, so the results may be applicable to a significant proportion of older adults. The main lim...
Source: NHS News Feed - January 27, 2015 Category: Consumer Health News Tags: Medication Neurology Source Type: news